fludarabine and cardiovascular agents

fludarabine has been researched along with cardiovascular agents in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cavaliere, AL; Coppola, C; Curcio, A; De Serio, D; Ellison, GM; Galuppo, V; Gasparri, C; Indolfi, C; Leone, A; Surace, FC; Torella, D1

Other Studies

1 other study(ies) available for fludarabine and cardiovascular agents

ArticleYear
Fludarabine prevents smooth muscle proliferation in vitro and neointimal hyperplasia in vivo through specific inhibition of STAT-1 activation.
    American journal of physiology. Heart and circulatory physiology, 2007, Volume: 292, Issue:6

    Topics: Angioplasty, Balloon; Animals; Aorta; Cardiovascular Agents; Carotid Artery Injuries; Carotid Stenosis; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Feasibility Studies; Hyperplasia; Janus Kinase 2; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphorylation; Prosthesis Design; Rabbits; Rats; Rats, Wistar; RNA, Antisense; STAT1 Transcription Factor; Stents; Time Factors; Transfection; Tunica Intima; Vidarabine

2007